메뉴 건너뛰기




Volumn 46, Issue 3, 2014, Pages 744-748

Experience of using everolimus in the early stage of living donor liver transplantation

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; EVEROLIMUS; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

EID: 84899542568     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.11.068     Document Type: Conference Paper
Times cited : (21)

References (13)
  • 1
    • 79960797525 scopus 로고    scopus 로고
    • Conversion to everolimus in maintenance liver transplant patients: A multicenter, retrospective analysis
    • F. Saliba, S. Dharancy, and J. Dumortier et al. Conversion to everolimus in maintenance liver transplant patients: a multicenter, retrospective analysis Liver Transplant 17 2011 905 913
    • (2011) Liver Transplant , vol.17 , pp. 905-913
    • Saliba, F.1    Dharancy, S.2    Dumortier, J.3
  • 2
    • 84863226512 scopus 로고    scopus 로고
    • A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation-PROTECT
    • L. Fischer, J. Klempnauer, and H.J. Schlitt et al. A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation-PROTECT Am J Transplant 12 2012 1855 1865
    • (2012) Am J Transplant , vol.12 , pp. 1855-1865
    • Fischer, L.1    Klempnauer, J.2    Schlitt, H.J.3
  • 3
    • 79952361568 scopus 로고    scopus 로고
    • Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: An open-label, randomised, controlled trial
    • K. Budde, T. Becker, and U. Eisenberger et al. Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial Lancet 377 2011 837 847
    • (2011) Lancet , vol.377 , pp. 837-847
    • Budde, K.1    Becker, T.2    Eisenberger, U.3
  • 4
    • 77957583305 scopus 로고    scopus 로고
    • Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial
    • J. Dantal, F. Berthoux, and R. Genin et al. Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial Transpl Int 23 2010 1084 1093
    • (2010) Transpl Int , vol.23 , pp. 1084-1093
    • Dantal, J.1    Berthoux, F.2    Genin, R.3
  • 5
    • 77952945224 scopus 로고    scopus 로고
    • Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients
    • H. Tedesco Silva Jr., D. Cibrik, and C. Panis et al. Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients Am J Transplant 10 2010 1401 1413
    • (2010) Am J Transplant , vol.10 , pp. 1401-1413
    • Tedesco Silva, Jr.H.1    Cibrik, D.2    Panis, C.3
  • 6
    • 68949212927 scopus 로고    scopus 로고
    • Indications and management of everolimus after liver transplantation
    • I. Bilbao, G. Sapisochin, and R. Charco et al. Indications and management of everolimus after liver transplantation Transplant Proc 41 6 2009 2172 2176
    • (2009) Transplant Proc , vol.41 , Issue.6 , pp. 2172-2176
    • Bilbao, I.1    Sapisochin, G.2    Charco, R.3
  • 7
    • 0038782051 scopus 로고    scopus 로고
    • Rapamycin: Friend, foe, or misunderstood?
    • J. Fung, and A. Marcos Rapamycin: friend, foe, or misunderstood? Liver Transpl 9 2003 469 472
    • (2003) Liver Transpl , vol.9 , pp. 469-472
    • Fung, J.1    Marcos, A.2
  • 8
    • 33751009117 scopus 로고    scopus 로고
    • Everolimus and mTOR inhibitors in liver transplantation: Opening the "box"
    • G.T. Everson Everolimus and mTOR inhibitors in liver transplantation: opening the "box" Liver Transplant 12 2006 1571
    • (2006) Liver Transplant , vol.12 , pp. 1571
    • Everson, G.T.1
  • 9
    • 43849095466 scopus 로고    scopus 로고
    • Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma
    • M.A. Zimmerman, J.F. Trotter, and I. Kam et al. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma Liver Transplant 14 2008 633 638
    • (2008) Liver Transplant , vol.14 , pp. 633-638
    • Zimmerman, M.A.1    Trotter, J.F.2    Kam, I.3
  • 10
    • 85172998912 scopus 로고    scopus 로고
    • Early withdrawal of calcineurin inhibitors and everolimus monotherapy in de novo liver transplant recipients preserves renal function
    • M. Masetti, R. Montalti, and G. Gerunda et al. Early withdrawal of calcineurin inhibitors and everolimus monotherapy in de novo liver transplant recipients preserves renal function Am J Transplant 10 2010 252 262
    • (2010) Am J Transplant , vol.10 , pp. 252-262
    • Masetti, M.1    Montalti, R.2    Gerunda, G.3
  • 11
    • 59249098555 scopus 로고    scopus 로고
    • Conversion to everolimus monotherapy in maintenance liver transplantation: Feasibility, safety, and impact on renal function
    • P. De Simone, P. Carrai, and A. Precisi et al. Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function Transpl Int 22 2009 279 286
    • (2009) Transpl Int , vol.22 , pp. 279-286
    • De Simone, P.1    Carrai, P.2    Precisi, A.3
  • 12
    • 37549021099 scopus 로고    scopus 로고
    • A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function
    • C.J. Watson, A.E. Gimson, and G.J. Alexander et al. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function Liver Transpl 13 2007 1694 1702
    • (2007) Liver Transpl , vol.13 , pp. 1694-1702
    • Watson, C.J.1    Gimson, A.E.2    Alexander, G.J.3
  • 13
    • 84868208723 scopus 로고    scopus 로고
    • Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: A randomized controlled trial
    • P. De Simone, F. Nevens, and G. Junge et al. Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial Am J Transplantation 12 11 2012 3008 3020
    • (2012) Am J Transplantation , vol.12 , Issue.11 , pp. 3008-3020
    • De Simone, P.1    Nevens, F.2    Junge, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.